{"id":"NCT00894387","sponsor":"Novartis Pharmaceuticals","briefTitle":"Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure","officialTitle":"A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the 6 Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality When Initiated Early After Hospitalization for Acute Decompensated Heart Failure","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05","primaryCompletion":"2012-08","completion":"2012-08","firstPosted":"2009-05-07","resultsPosted":"2013-10-10","lastUpdate":"2013-11-07"},"enrollment":1639,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Decompensated Heart Failure","Congestive Heart Failure"],"interventions":[{"type":"DRUG","name":"Aliskiren","otherNames":["Aliskiren速,","Tekturna速,","Rasilez速,","SPP100"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Aliskiren","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study evaluated the effect of early initiation of aliskiren therapy, compared to standard therapy, in the reduction of cardiovascular death and heart failure re-hospitalization events within 6 months, in congestive heart failure (CHF) patients hospitalized for an episode of acute decompensated heart failure.","primaryOutcome":{"measure":"Time to Event Analysis: Number of Patients Experienced the First Confirmed Occurrence of Either Cardiovascular Death or Heart Failure (HF) Re-hospitalization Within 6 Months","timeFrame":"6 months","effectByArm":[{"arm":"Aliskiren","deltaMin":201,"sd":null},{"arm":"Placebo","deltaMin":214,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":308,"countries":["United States","Argentina","Belgium","Brazil","Canada","Colombia","Czechia","Finland","France","Germany","Hungary","India","Israel","Italy","Philippines","Poland","Romania","Russia","Singapore","Slovakia","Spain","Sweden","Taiwan","Turkey (T端rkiye)"]},"refs":{"pmids":["29143416","29044915","28960673","23478743","21123186"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":421,"n":808},"commonTop":["Hyperkalaemia","Hypotension","Cough","Hypokalaemia","Diarrhoea"]}}